Regen Biopharma, Inc. (QB)
Ticker Symbol: OTCBB:RGBP
OTC Market Tier: Pink Limited
CIK Number: 0001589150
Security Type: Common Stock
RGBP Address: 4700 Spring Street
Suite 304
La Mesa, California 91942
RGBP Country: USA
RGBP Phone: (619) 702-1404
RGBP Fax #: 619 330 2328
Description: Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized: 1,800,000,000
Shares Outstanding: 518,452,006
Shares Outstanding Date: 06/11/2019
Shares Holder Count: 467
Shares Holder Date: 12/27/2018
Market Capitalization: $ 414,761.60
Key Executives: Dr. Harry Lander - CSO
Number of Employees: 4
Incorporation State: NV
Incorporation Country: USA
Incorporation Year: 2012
Auditor: Prager Metis CPAs LLC
Auditor Address: 15 Warren Street
Suite 25
Hackensack, NJ 07601
United States
Auditor Website:
IR Firm: N/A
Legal Counsel: N/A
Fiscal Year End: 9/30
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: Securities Transfer Corporation
TA Address: 2901 Dallas Parkway
Suite 380
Plano, TX 75093
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 9,252
Short Date: 03/15/2019
Closing MMID: 11
BFCMmid: 10
Tier ID: 21
Status: Active
Your Recent History
Regen Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190619 13:50:57